New recommendations from Innovative Medicines Initiative project PREFER detail when and how best to incorporate patient preferences into drug development processes.

IMI project RESCEU is shedding new light on the burden of respiratory syncytial virus, a common infectious disease that can cause serious illness in young children and other vulnerable groups.

The Innovative Medicines Initiative project ConcePTION is exploring how a learning healthcare system approach could advance medicines safety during pregnancy and breastfeeding.

Age-related macular degeneration (AMD) is a leading cause of blindness. The EMA has issued a Letter of Support to Innovative Medicines Initiative project MACUSTAR for its work on new measures to assess AMD in clinical trials.

IMI-funded researchers found that COVID-19 vaccines do not raise the risk of developing four rare neurological disorders, but an increased risk was seen in unvaccinated infected people with the disease.

Scientists from Innovative Medicines Initiative projects iPiE and PREMIER used a tool called ePiE to predict levels of ibuprofen in four major European river basins.

Innovative Medicines Initiative project imSAVAR reviewed the state of ‘cancer-on-chip’ technology. While promising, problems with manufacturing to scale make them impractical for the moment.

The Innovative Medicines Initiative project ITCC-P4 helped identify some of the best targets in childhood tumours that could be candidates for treatment with adult therapies.

Innovative Medicines Initiative project COMBACTE-CDI shed new light on the highly contagious bug Clostridioides difficile and sequenced the genomes of hundreds of strains for future researchers.

The Innovative Medicines Initiative’s European Lead Factory has helped identify two drug candidates for cancer treatment that have now progressed to clinical testing.